entity

phase_separation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about phase_separation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections

9Hypotheses

8Analyses

0Outgoing

3Incoming

11Experiments

9Debates

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

fus-phase-separation-neurodegeneration

mechanism · 1409 words

→

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (3)

Source	Relation	Type	Str
dilncRNA	drives	RNA	0.70
IDR_domains	mediates	protein_domain	0.70
TP53BP1	undergoes	gene	0.70

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43	0.820	neurodegeneration	What is the therapeutic window between i
Stress Granule Phase Separation Modulators	0.720	neurodegeneration	RNA binding protein dysregulation across
TRIM21 as a 'Phase Separation Thermostat' via Catalytic Reve	0.700	neurodegeneration	How does TRIM21-mediated K63 ubiquitinat
p62 Liquid-Liquid Phase Separation Nucleates Cross-Organelle	0.649	neurodegeneration	How do different organelle-specific auto
Small Molecule Modulation of Phase Separation	0.640	neurodegeneration	What determines the specificity of RNA-p

Hierarchical Phase Separation with Scaffold Cores	0.630	neurodegeneration	What determines the specificity of RNA-p
ALS-Associated G3BP1 Mutations Shift Phase Separation Equili	0.610	neurodegeneration	How do disease-associated mutations in G
Liquid-Liquid Phase Separation Modifier Therapy	0.551	neurodegeneration	Protein aggregation cross-seeding across
Liquid-Liquid Phase Separation (LLPS) Saturation Partitionin	0.461	neurodegeneration	What determines the spatial organization

Mentioning Analyses (8)

Scientific analyses that reference this entity

What determines the temporal transition from protective to pathological stress g

neurodegeneration | 2026-04-12 | 0 hypotheses

What are the specific design principles for small molecules that can selectively

medicinal chemistry | 2026-04-10 | 0 hypotheses

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

neurodegeneration | 2026-04-08 | 0 hypotheses

How do dilncRNAs specifically drive molecular crowding and phase separation of D

neurodegeneration | 2026-04-08 | 0 hypotheses

What determines the specificity of RNA-protein interactions that drive distinct

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.710

Experiments (11)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
G3BP1-mediated stress granule assembly via liquid-liquid phase separat	exploratory		0.900	0.00	eukaryotic cells	proposed	N/A
TRIM21 E3 ubiquitin ligase screen for stress granule regulation	exploratory	neurodegenerative diseases	0.900	0.00	cultured cells	proposed	N/A
G3BP1 intrinsically disordered region analysis and phosphorylation eff	exploratory		0.850	0.00	in vitro protein analysis syst	proposed	N/A
G3BP1-binding factor cooperativity in stress granule network regulatio	exploratory		0.800	0.00	cell culture systems with prot	proposed	N/A
Proposed experiment from debate on TDP-43 undergoes liquid-liquid phas	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val	validation	Neurodegeneration	0.400	0.50	human	proposed	$3,000,000
Multiscale Computational Modeling of Protein Aggregation Kinetics	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,280,000
Pre-Symptomatic Detection and Intervention Timing in Genetic Prion Dis	validation	ALS	0.400	0.50	human	proposed	$2,280,000
Protein Aggregation Kinetic Validation Results	validation	Neurodegeneration	0.400	0.50	in_silico	proposed	$120,000
Stress Granule Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3B [PMID:36692217]	Yang C, Wang Z, Kang Y, Yi Q, Wang T, Ba	Autophagy	2023	3
G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Gran [PMID:32302571]	Yang P, Mathieu C, Kolaitis RM, Zhang P,	Cell	2020	3
LINC00599 Promotes Pulmonary Hypertension via Liquid-Liquid Phase Separation Wit [PMID:40693377]	Wang Y, Yin L, Zheng S, Liu A, Liu C, Ba	Hypertension	2025	1
The important role of stress granules in prostate cancer development, progressio [PMID:40972860]	Xu Z, You H, Gu J, Jiang J, Yan Z, Jin X	Gene	2025	1
Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specifi [PMID:34739333]	Gwon Y, Maxwell BA, Kolaitis RM, Zhang P	Science	2021	1
STING is the scaffold protein for stress granule pre-condensation at the ER. [PMID:41917183]	Eom E, Kim J, Kim J, Kang SJ	Cell death and differentiation	2026	0
Stress granules: Guardians of cellular health and triggers of disease. [PMID:39995077]	["Desai M", "Gulati K", "Agrawal M", "Gh	Neural regeneration research	2026	0
WFDC21P is essential for G3BP1-mediated RIG-I activation and antitumor immunity [PMID:41915747]	Li Z, Wang Y, Chen Z, Liu R, Lai ZH, Li	Proceedings of the National Ac	2026	0
NUP93 facilitates the nuclear import of SOX2 to activate G3BP1 transcription and [PMID:41896201]	Sun H, Yang C, Du J, Xu C, Chen Y, Chen	Cell death & disease	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Translational neurodegeneratio	2026	0
Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by sup [PMID:41920932]	Mulloy RP, Evseev D, Sharlin N, Bui-Mari	PLoS biology	2026	0
Stress granules: Guardians of cellular health and triggers of disease. [PMID:39995077]	Desai M, Gulati K, Agrawal M, Ghumra S,	Neural Regen Res	2026	0
Implications of virus-induced stress granules in tauopathies. [PMID:41673769]	Sharma S, Vandenakker A, Cortés-Pérez C,	Transl Neurodegener	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Front Pharmacol	2026	0
Stress granules at the crossroads of retroviral replication and antiviral immuni [PMID:41931190]	Akbarin MM, Farjami Z, Álvarez HR	Mol Biol Rep	2026	0
Pharmacological modulation of stress granules via G3BP1/2: A pathway to treat ca [PMID:41924133]	Yang J, Gao F	Frontiers in pharmacology	2026	0
Disruption of G3BP1 granules promotes mammalian CNS and PNS axon regeneration. [PMID:40014573]	["Sahoo P", "Agrawal M", "Hanovice N", "	Proceedings of the National Ac	2025	0
RIOK1 phase separation restricts PTEN translation via stress granules activating [PMID:40467995]	["Meng F", "Li H", "Huang Y", "Wang C",	Nature cancer	2025	0
β-propeller protein-associated neurodegeneration protein WDR45 regulates stress [PMID:40473629]	["Li Y", "Fang J", "Ding Y", "Zhang X",	Nature communications	2025	0
Identification of small molecule inhibitors of G3BP-driven stress granule format [PMID:38284934]	["Freibaum B", "Messing J", "Nakamura H"	The Journal of cell biology	2024	0

Debates (9)

Multi-agent debates referencing this entity

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

closed · Rounds: 4 · Score: 0.79 · 2026-04-21

While the study identifies G3BP1 as a central node triggering phase separation,

closed · Rounds: 4 · Score: 0.76 · 2026-04-21

The debate identified that TDP-43 undergoes both normal and pathological phase s

closed · Rounds: 4 · Score: 0.43 · 2026-04-21

The debate revealed that stress granules can be both neuroprotective and patholo

closed · Rounds: 4 · Score: 0.86 · 2026-04-16

TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small

closed · Rounds: 6 · Score: 0.84 · 2026-04-12

TDP-43 phase separation therapeutics for ALS-FTD

closed · Rounds: 4 · Score: 0.95 · 2026-04-11

The abstract shows that dilncRNAs drive molecular crowding of DDR proteins into

closed · Rounds: 7 · Score: 0.90 · 2026-04-10

While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it's

closed · Rounds: 7 · Score: 0.95 · 2026-04-10

What are the mechanisms underlying tdp-43 phase separation therapeutics for als-

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning phase_separation in their description or question text

Hierarchical Phase Separation with Scaffold Cores

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The hierarchical phase separation model proposes a sophisticated two-tier mechani

ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberran

Score: 0.610 · neurodegeneration · 2026-04-22

## Mechanistic Overview ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberrant Condensate Sta

Liquid-Liquid Phase Separation Modifier Therapy

Score: 0.551 · neurodegeneration · 2026-04-02

Compounds that modulate the surface tension and composition of biomolecular condensates could prevent the aberrant mixin

Liquid-Liquid Phase Separation (LLPS) Saturation Partitioning Excludes Autophagy

Score: 0.461 · neurodegeneration · 2026-04-21

## Mechanistic Overview Liquid-Liquid Phase Separation (LLPS) Saturation Partitioning Excludes Autophagy Receptors from

phase_separation

Understanding Entity Pages

Wiki Pages (1)

fus-phase-separation-neurodegeneration

Outgoing (0)

Incoming (3)

Targeting Hypotheses (9)

Mentioning Analyses (8)

What determines the temporal transition from protective to pathological stress g

What are the specific design principles for small molecules that can selectively

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

How do dilncRNAs specifically drive molecular crowding and phase separation of D

What determines the specificity of RNA-protein interactions that drive distinct

How does TRIM21-mediated K63 ubiquitination of G3BP1 mechanistically inhibit liq

TDP-43 phase separation therapeutics for ALS-FTD

TDP-43 phase separation therapeutics for ALS-FTD

Experiments (11)

Related Papers (20)

Debates (9)

The study shows that G3BP1 ubiquitination inhibits LLPS in vitro, but the molecu

While the study identifies G3BP1 as a central node triggering phase separation,

The debate identified that TDP-43 undergoes both normal and pathological phase s

The debate revealed that stress granules can be both neuroprotective and patholo

TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small

TDP-43 phase separation therapeutics for ALS-FTD

The abstract shows that dilncRNAs drive molecular crowding of DDR proteins into

While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it's

What are the mechanisms underlying tdp-43 phase separation therapeutics for als-

Related Research

Hierarchical Phase Separation with Scaffold Cores

ALS-Associated G3BP1 Mutations Shift Phase Separation Equilibrium Toward Aberran

Liquid-Liquid Phase Separation Modifier Therapy

Liquid-Liquid Phase Separation (LLPS) Saturation Partitioning Excludes Autophagy